Leadership

Scientific leadership

S&K Therapeutics is led by Sangdun Choi, Ph.D., Founder & CEO, with a scientific focus on immune signaling and molecular approaches to tissue regeneration.

SCFOUNDER · SCIENTIST · CEO

Founder & CEO

Sangdun Choi, Ph.D.

Professor at Ajou University for 20 years

Drawing on 20 years as a professor at Ajou University, where he led research in immune signaling and computational molecular design, Sangdun Choi founded S&K Therapeutics to translate this scientific foundation into therapeutic development.

As Founder & CEO, he leads the company's scientific direction across Innate Immune Signaling Modulation and Regenerative Peptide Therapeutics, supported by computational molecular design and experimental biology.

Clearly defined scientific questions and careful interpretation of evidence guide the next step in development.

Connect with S&K →